Global T Cell Immunotherapy Market Report to 2027 –

Dublin, July 21, 2022 (GLOBE NEWSWIRE) — The “T Cell Immunotherapy Market Intelligence Report – Global Forecast to 2027” report has been added to from offer.

The global T Cell Immunotherapy Market is expected to reach USD 9,684.58 Million by 2027, from USD 4,712.10 Million in 2021, at a CAGR of 12.75% during the forecast period.

Market statistics:

The report provides market size analysis and forecasts for 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD and CHF. It helps organizational leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year and the years from 2023 to 2027 as the forecast period.

  • The Americas T Cell Immunotherapy Market Size was estimated at USD 1,633.21 Million in 2021 and is projected to reach USD 1,848.63 Million in 2022, at a CAGR of 12.92% to reach 3,386.23 million USD by 2027.
  • The Asia-Pacific T-cell immunotherapy market size was estimated at USD 1,076.95 million in 2021 and is projected to reach USD 1,237.07 million in 2022, at a CAGR of 13.46% to reach 2,297 .78 million USD by 2027.
  • The Europe, Middle East & Africa T Cell Immunotherapy market size was estimated at USD 2,001.93 million in 2021 and is projected to reach USD 2,224.18 million in 2022, at a CAGR of 12. 23% to reach USD 4,000.57 million by 2027.

Segmentation and market coverage:

The T Cell Immunotherapy report identifies key customer attributes to define the potential market and identify various needs in the industry. Understanding the economies and geographies of the potential customer group can help build business acumen for better strategic decision-making.

Market coverage in different industry verticals reveals the hidden truth about the strategies of players in different verticals and helps the organization decide on the target audience. This report gives you a composite view of the sub-markets coupled with comprehensive industry coverage and provides you with the right method of accounting factors such as standards and regulations, culture, to build the right hedging strategy for your market plan. market.

Main topics covered:

1. Preface
1.1. Study objectives
1.2. Market segmentation and coverage
1.3. Years Considered for Study
1.4. Currency and price
1.5. Language
1.6. Limits
1.7. Hypotheses
1.8. Stakeholders

2. Research methodology
2.1. Define: research objective
2.2. Determine: research design
2.3. Prepare: finding aid
2.4. Collect: Data Source
2.5. Analysis: Interpretation of data
2.6. Formula: data verification
2.7. Publish: Research report
2.8. Repeat: report update

3. Market Overview

4. Americas T Cell Immunotherapy Market
4.1. Introduction
4.2. Argentina
4.3. Brazil
4.4. Canada
4.5. Mexico
4.6. United States

5. Asia Pacific T Cell Immunotherapy Market
5.1. Introduction
5.2. Australia
5.3. China
5.4. India
5.5. Indonesia
5.6. Japan
5.7. Malaysia
5.8. Philippines
5.9. Singapore
5.10. South Korea
5.11. Taiwan
5.12. Thailand

6. Europe, Middle East and Africa T Cell Immunotherapy Market
6.1. Introduction
6.2. France
6.3. Germany
6.4. Italy
6.5. Netherlands
6.6. Qatar
6.7. Russia
6.8. Saudi Arabia
6.9. South Africa
6.10. Spain
6.11. United Arab Emirates
6.12. UK

7. Enterprise Usability Profiles
7.1. Adaptimmune Therapeutics PLC
7.2. Apac-Biotech
7.3. Atara Biotherapeutics, Inc.
7.4. Autolus Limited
7.5. bluebird bio, inc.
7.6. Bristol-Myers Squibb Company
7.7. CARsgen Therapeutics, Ltd
7.8. Cellectis SA
7.9. Bioengineering Chimera
7.10. Dendreon Pharmaceuticals LLC
7.11. Eureka Therapeutics, Inc.
7.12. Gilead Sciences, Inc.
7.13. Green Cross Society
7.14. Innovative Cellular Therapeutics
7.15. Iovance Biotherapeutics, Inc.
7.16. JW CreaGene Co., Ltd.
7.17. LAVA Therapeutic BV
7.18. Lyell Immunopharma
7.19. Neogene therapy
7.20. NeoTX Therapeutics
7.21. Novartis AG
7.22. Oxford Vacmedix
7.23. Therapeutic Poseida
7.24. TScan Therapeutics, Inc.
7.25. Xenetic Biosciences
7.26. ZIOPHARM Oncology

For more information on this report, visit


About Troy McMiller

Check Also

Wall Street rallies for its best week since June on rate hopes

NEW YORK (AP) — Wall Street racked up more gains Friday on its massive one-day …